Cargando…
Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
In the last decades three-dimensional (3D) in vitro cancer models have been proposed as a bridge between bidimensional (2D) cell cultures and in vivo animal models, the gold standards in the preclinical assessment of anticancer drug efficacy. 3D in vitro cancer models can be generated through a mult...
Autores principales: | Tosca, Elena M., Ronchi, Davide, Facciolo, Daniele, Magni, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136119/ https://www.ncbi.nlm.nih.gov/pubmed/37189676 http://dx.doi.org/10.3390/biomedicines11041058 |
Ejemplares similares
-
The national centre for the replacement, refinement, and reduction of animals in research
por: Singh, Jatinder
Publicado: (2012) -
Application of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules
por: Tosca, Elena M., et al.
Publicado: (2021) -
Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities
por: Akkermans, Arnoud, et al.
Publicado: (2020) -
A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in in vivo xenograft studies
por: Tosca, Elena Maria, et al.
Publicado: (2021) -
Survey of Canadian Animal-Based Researchers' Views on the Three Rs: Replacement, Reduction and Refinement
por: Fenwick, Nicole, et al.
Publicado: (2011)